Ксероз кожи – основной патогенетический фактор развития атопического дерматита

1. Сергеев Ю.В. Атопический дерматит. Руководство для врачей. М.: Медицина для всех, 2002; с. 187.
2. Cork M, Danby S, Vasilopoulos Y et al. Epidermal Barrier Dysfunction in Atopic Dermatitis Journal of Investigative Dermatology. 2009; 129: 1892–908.
3. Baena-Cagnani C, Serra H, Teijero A, Croce JS. Prevention of allergy and asthma. Clin Exp All Rev 2003; 3: 51–7. 
4. Pawankar R, Canonica GW, Holgate ST, Lockey RF. WAO White Bookon Allergy 2011–2012: WAO, 2011, Milwaukee, Wisconsin, USA 1-220, http://www.worldallergy.org/UserFiles/file/WAO-White-Book-on-Allergy_web.pdf
5. Kamer B, Pasowska R, Dólka E et al. Prevalence of atopic dermatitis in infants during the first six months of life: authors’ observations. Postep Derm Alergol 2013; 30: 277–81.
6. Besnier E. Premiere note et observations preliminares pour servir introduction a Petude des prurigo diathesiques .Ann Dermatol Syphil 1892; 23: 634–48.
7. Суворова К.Н., Куклин В.Т., Рукавишникова В.М. Детская дерматология. Казань, 1996. 
8. Sandford A.J, Shirakawa T, Moffatt MF et al. Location of atopy and beta subunit of high affinity (Fc epsilon RI) on chromosome 11q. Lancet 1993; 341: 332–4.
9. Imahara SD, O’Keefe GE. Genetic determinants of the inflammatory response. Curr Opin Crit Care 2004; 10 (5): 318–24.
10. Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci 2010; 58 (1): 1–7.
11. Maggi E. The TH1/TH2 paradigm in allergy. Immunotechnology 1998; 3: 233–44.
12. Oettgen HC, Geha RS. IgE in asthma and atopy: cellular and molecular connections. 
J Clin Invest 1999; 104: 829–35.
13. Dušan Sajić,  Rachel Asiniwasis. A Look at Epidermal Barrier Function in Atopic Dermatitis: Physiologic Lipid Replacement and the Role of Ceramide. http://www.skintherapyletter.com/2012/17.7/2.html
14. Elias P, Hatano W. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 2008; 121: 1337–43.
15. Volz A, Konge BP, Compton JG et al. Physical mapping of a functional cluster of epidermal differentiation gens on chromosome 1q21. Genomics1993; 18: 92–9.
16. Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Allergy Asthma Rep 2009; 9 (4): 265–72.
17. Jensen, J, Folster-Holst R, Baranowsky A et al. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004; 122: 1423–31.
18. Ponec M, Lankhorst P, Weerheim A, Wertz P. Newacyl ceramide in native and reconstructed epidermis. J Invest Dermatol 2003; 120: 581–8. 
19. Musakawa Y, Narita H, Shimizu E et al. Characterization of overall ceramides pecies in human stratum corneum. J Lipid Res 2008; 49: 1466–67.
20. Bouwstra JA, Gooris GS, Dubbelaar FE et al. Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J Lipid Res 1998; 1: 186–96.
21. Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta 2006; 1758 (12): 2080–95. 
22. Scott IR, Harding CR. Filagrrin break down to water binding compounds during development of the ratstratum corneum is controlled by the water activity of the environment. Dev Biol 1986; 115: 84–92.
23. Bouwstra JA, Groenink HW, Kempenaar JA et al. Water distribution and natural moisturizer factor content in human skin equivalents are regulated by environmental relative humidity. J Invest Dermatol 2008;125: 288–93.
24. Palmer K, Irvine A, Terron-Kwiatkows A, Zhao Y. Common less-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441–6.
25. Smith FJD, Irvine AD, Terron-Kwiatkowski A. Loss-of-function mutation in the gene encoding filaggrin cause ichthyosis vulgaris. Natur Genet. 2006; 38: 337–42.
26. Kezic S. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy 2011; 66 (7): 934–40.
27. Bonnelykke K, Pipper CB, Tavendale R et al. Filaggrin gene variants and atopic diseases in early childhood assessed longitudinally from birth. Pediatr Allergy Immunol 2010; 21:954–61.
28. Kato A, Fukai K, Oiso N et al. Associationof SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol 2003; 148: 665–69.
29. Walley AJ, Cnavanas S, Moffatt MF et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet. 2001; 29: 175–8.
30. Tagami H, Kobayashi H, O'goshi K, Kikuchi K. Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products. J Cosmet Dermatol 2006; 5 (2): 140–9.
31. Sugarman JL, Fluhr JW, Fowler AJ et al. The objective severity assessment in atopic dermatitis (OSAAD) score: An objective measure utilizing permeability barrier function and stratum corneum hydration, with computer-assisted estimates for extent of disease. Arch Dermatol 2003; 139 (11): 1417–22.
32. Seidenari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 1995;75 (6): 429–33.
33. Loden M, Maibach HI. Treatment of Dry Skin Syndrome. Springer-Verlag Berlin Heidelberg, 2012.
34. Elias PM. An Appropriate response to the black-box warning: corrective, barrier repair therapy in atopic dermatitis. Clin Med Dermatol 2009; 2: 1–3.
35. Тамразова О.Б. Синдром сухой кожи. Cons. Med. Дерматология. 2014; 3: 8–14.

О.Б.Тамразова, А.В.Молочков
Кафедра дерматовенерологии ФПК МР РУДН, Москва